Brad Douglas Anderson, MD | |
90 Health Park Dr, Suite 260, Louisville, CO 80027-9757 | |
(303) 673-9090 | |
(303) 673-9195 |
Full Name | Brad Douglas Anderson |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 39 Years |
Location | 90 Health Park Dr, Louisville, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558362657 | NPI | - | NPPES |
50305255 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 37641 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Tru Community Care - Lafayette | Lafayette, CO | Hospice |
Peaks Care Center The | Longmont, CO | Nursing home |
Applewood Living Center | Longmont, CO | Nursing home |
Alpine Living Center | Thornton, CO | Nursing home |
North Shore Health & Rehab Facility | Loveland, CO | Nursing home |
Villas At Sunny Acres, The | Thornton, CO | Nursing home |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Meadows Family Medical Center Inc | 0446151617 | 98 |
News Archive
Osiris Therapeutics, Inc., the leading stem cell company developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that the European Medicines Agency (EMA) has designated Osiris as the Orphan Drug title holder for Prochymal (remestemcel-L).
Queensland University of Technology researchers have applied artificial intelligence deep learning techniques to develop a more accurate and detailed method for analyzing images of the back of the eye to help clinicians better detect and track eye diseases, such as glaucoma and age-related macular degeneration.
Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL.
Britain's top cancer scientists claim that men's health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.
› Verified 2 days ago
Entity Name | Meadows Family Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962440412 PECOS PAC ID: 0446151617 Enrollment ID: O20040120000416 |
News Archive
Osiris Therapeutics, Inc., the leading stem cell company developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that the European Medicines Agency (EMA) has designated Osiris as the Orphan Drug title holder for Prochymal (remestemcel-L).
Queensland University of Technology researchers have applied artificial intelligence deep learning techniques to develop a more accurate and detailed method for analyzing images of the back of the eye to help clinicians better detect and track eye diseases, such as glaucoma and age-related macular degeneration.
Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL.
Britain's top cancer scientists claim that men's health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Brad Douglas Anderson, MD 5920 Mcintyre St, Golden, CO 80403-7445 Ph: (720) 434-4876 | Brad Douglas Anderson, MD 90 Health Park Dr, Suite 260, Louisville, CO 80027-9757 Ph: (303) 673-9090 |
News Archive
Osiris Therapeutics, Inc., the leading stem cell company developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that the European Medicines Agency (EMA) has designated Osiris as the Orphan Drug title holder for Prochymal (remestemcel-L).
Queensland University of Technology researchers have applied artificial intelligence deep learning techniques to develop a more accurate and detailed method for analyzing images of the back of the eye to help clinicians better detect and track eye diseases, such as glaucoma and age-related macular degeneration.
Sanofi announced today that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin. The fixed-ratio combination of insulin glargine 100 units/mL and lixisenatide, a GLP-1 RA, demonstrated statistically superior reduction in HbA1c (average blood glucose over the previous three months) compared with lixisenatide and compared with insulin glargine 100 units/mL.
Britain's top cancer scientists claim that men's health is at risk because the current test for prostate cancer is inadequate. The warning comes as The Institute of Cancer Research launches the 7th Everyman Male Cancer Awareness Month to alert men to the risk of prostate and testicular cancer.
› Verified 2 days ago
Dr. Lora Leigh Bulmahn, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 325 W South Boulder Rd, Suite #1, Louisville, CO 80027 Phone: 303-666-4949 Fax: 303-666-4950 | |
Dr. Daniel Conrad Laperriere, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Century Cir Ste 102, Louisville, CO 80027 Phone: 720-634-3870 Fax: 303-209-4645 | |
Dr. Carl Elwood Meredith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1044 S 88th St, Suite 200, Louisville, CO 80027 Phone: 303-666-7119 | |
Dr. Kevin Scott Boehm, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1044 S 88th St Ste 2, Louisville, CO 80027 Phone: 303-666-7119 Fax: 303-666-0220 | |
Randolph Pinto, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 80 Health Park Dr, Suite 100, Louisville, CO 80027 Phone: 303-666-2710 | |
Dr. Terry Lee Hackney, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 333 W South Boulder Rd, Ste 1, Louisville, CO 80027 Phone: 303-666-4313 Fax: 303-666-4369 | |
Dr. Elaine Stephanie Rusin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Health Park Dr, Louisville, CO 80027 Phone: 720-330-3937 |